- Home
- ENSC vs VEEE Comparison
ENSC vs VEEE Comparison
Compare ENSC & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- VEEE
- Stock Information
- Founded
- ENSC 2003
- VEEE 1994
- Country
- ENSC United States
- VEEE United States
- Employees
- ENSC N/A
- VEEE N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- ENSC Health Care
- VEEE Industrials
- Exchange
- ENSC Nasdaq
- VEEE Nasdaq
- Market Cap
- ENSC 6.4M
- VEEE 5.3M
- IPO Year
- ENSC N/A
- VEEE 2021
- Fundamental
- Price
- ENSC $2.55
- VEEE $2.28
- Analyst Decision
- ENSC
- VEEE
- Analyst Count
- ENSC 0
- VEEE 0
- Target Price
- ENSC N/A
- VEEE N/A
- AVG Volume (30 Days)
- ENSC 174.0K
- VEEE 781.1K
- Earning Date
- ENSC 11-11-2025
- VEEE 11-13-2025
- Dividend Yield
- ENSC N/A
- VEEE N/A
- EPS Growth
- ENSC N/A
- VEEE N/A
- EPS
- ENSC N/A
- VEEE N/A
- Revenue
- ENSC $7,413,722.00
- VEEE $13,153,262.00
- Revenue This Year
- ENSC N/A
- VEEE N/A
- Revenue Next Year
- ENSC $1,354.55
- VEEE N/A
- P/E Ratio
- ENSC N/A
- VEEE N/A
- Revenue Growth
- ENSC 415.58
- VEEE N/A
- 52 Week Low
- ENSC $1.62
- VEEE $1.86
- 52 Week High
- ENSC $14.67
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- ENSC 64.39
- VEEE 41.53
- Support Level
- ENSC $2.19
- VEEE $2.30
- Resistance Level
- ENSC $2.50
- VEEE $2.64
- Average True Range (ATR)
- ENSC 0.21
- VEEE 0.16
- MACD
- ENSC 0.01
- VEEE -0.06
- Stochastic Oscillator
- ENSC 64.53
- VEEE 4.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.